Components of the interleukin-33/ST2 system are differentially expressed and regulated in human cardiac cells and in cells of the cardiac vasculature

Svitlana Demyanets(Medical University of Vienna), Johann Wojta(Medical University of Vienna), Richard Pentz(Medical University of Vienna), Sabine Rauscher(Medical University of Vienna), Gerald Maurer(European Society of Radiology), Stefan Pfaffenberger(Medical University of Vienna), Kurt Huber(Sigmund Freud Privatuniversität Wien), Marion Gröger(Medical University of Vienna), Christoph Kaun(University of Vienna), Konstantin A. Krychtiuk(Ludwig Boltzmann Institute for Cardiovascular Research), A.Z. Aliabadi(Medical University of Vienna), Andreas Zuckermann(Medical University of Vienna)
Journal of Molecular and Cellular Cardiology
April 6, 2013
10.1016/j.yjmcc.2013.03.020
Cited by 166

Related Papers

ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation
|European Heart Journal|2012|6.8k
Risk of Bleeding With 2 Doses of Dabigatran Compared With Warfarin in Older and Younger Patients With Atrial Fibrillation
|Circulation|2011|1.1k
Myocardial Viability and Survival in Ischemic Left Ventricular Dysfunction
|New England Journal of Medicine|2011|877
Ticagrelor plus aspirin for 1 month, followed by ticagrelor monotherapy for 23 months vs aspirin plus clopidogrel or ticagrelor for 12 months, followed by aspirin monotherapy for 12 months after implantation of a drug-eluting stent: a multicentre, open-label, randomised superiority trial
|The Lancet|2018|793
Thrombin-Receptor Antagonist Vorapaxar in Acute Coronary Syndromes
|New England Journal of Medicine|2011|755